Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Brigette Ma

Professor

The Chinese University of Hong Kong (CUHK)

Hong Kong

Research Interests

Explore related searches

Professors in Immunology

Articles (20)

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Collaborators (9)

Bonan Chen

Research Assistant Professor

The Chinese University of Hong Kong (CUHK)

HONG KONG

View details

Charu Aggarwal

University of Pennsylvania

UNITED STATES

View details

Jason Chan

Associate Professor

The Chinese University of Hong Kong (CUHK)

HONG KONG

View details

Salvatore Alfieri

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Lorraine Chantrill

Head of Department

AUSTRALIA

View details

Kam Tong Leung

Assistant Professor

The Chinese University of Hong Kong (CUHK)

HONG KONG

View details

Canbin Fang

Clinical Lecturer

The Chinese University of Hong Kong (CUHK)

HONG KONG

View details

Ka-Wai Kwok

Professor

The Chinese University of Hong Kong (CUHK)

CHINA

View details

Woong-Yang Park

Professor

Sungkyunkwan University

SOUTH KOREA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Brigette Ma

Research Interests

Explore related searches

Articles (20)

Impact of Antibiotic Use in the Primary Treatment of Nasopharyngeal Carcinoma

Achieving control of nasopharyngeal carcinoma: the role of Epstein–Barr virus-based screening and vaccines

Corrigendum to “Tumor molecular landscape of Epstein-Barr virus (EBV) related nasopharyngeal carcinoma in EBV-endemic and non-endemic areas: Implications for improving treatment modalities” [Transl. Res. 265 (2024) 1-16, (S1931524423001780), (10.1016/j.trsl.2023.10.004)]

Precision Oncology: A Global Perspective on Implementation and Policy Development

A first-in-human phase 1/2 dose-escalation study of MAK683 (EED inhibitor) in patients with advanced malignancies

Author Correction: Evolving landscape of nasopharyngeal carcinoma therapy (Nature Cancer, (2025), 6, 9, (1480-1482), 10.1038/s43018-025-01045-7)

Change in diffusion weighted imaging after induction chemotherapy outperforms RECIST guideline for long-term outcome prediction in advanced nasopharyngeal carcinoma

Deep Invasion Volume of the Primary Nasopharyngeal Carcinoma Predicts Treatment Outcome

Evolving landscape of nasopharyngeal carcinoma therapy

Expert consensus on the optimal management of BRAFV600E-mutant metastatic colorectal cancer in the Asia-Pacific region

Fragmentomics profiling and quantification of plasma Epstein-Barr virus DNA enhance prediction of future nasopharyngeal carcinoma

ISG15 mRNA transcript level in circulating leucocytes prognostic of overall survival in hepatocellular carcinoma patients and correlated with quality of life disturbances involved in anorexia-cachexia

Management approaches for recurrent or metastatic head and neck squamous cell carcinoma after anti-PD-1/PD-L1 immunotherapy

Predictive markers for head and neck cancer treatment response: T1rho imaging in nasopharyngeal carcinoma

STK3 is a transcriptional target of YAP1 and a hub component in the crosstalk between Hippo and Wnt signaling pathways during gastric carcinogenesis

The arrival of antibody drug conjugates in nasopharyngeal cancer

The potential of real-time dynamic disease monitoring with circulating tumor DNA: important lessons from Epstein-Barr virus-related nasopharyngeal carcinoma

Optimizing Hearing Outcomes in Nasopharyngeal Cancer Survivors in the Era of Modern Radiotherapy and Systemic Therapy

A phase 2, multicenter, open-label study of anti-LAG-3 ieramilimab in combination with anti-PD-1 spartalizumab in patients with advanced solid malignancies

Clinical Management of Gastrointestinal and Liver Toxicities of Immune Checkpoint Inhibitors

Collaborators (9)

Bonan Chen

Charu Aggarwal

Jason Chan

Salvatore Alfieri

Lorraine Chantrill

Kam Tong Leung

Canbin Fang

Ka-Wai Kwok

Woong-Yang Park

Make your next move.